CD44 and breast carcinoma: In conclusion, modification of LNPswith the CD44-specific AKPClipopeptide greatly enhanced the in vivo tumor targetabilityof LNPs to breast cancer cells that had metastasized to the tail andwere located in situ in the hindbrain.